Rite Aid maintained its same-store sales momentum, posting gains across front-end and pharmacy comparable sales for the sixth consecutive quarter: Overall same-store sales were up 2.5%, reflecting a 2.7% increase across the front-end and a 2.4% uptick across pharmacy, for the first quarter ended June 2. Comparable prescriptions filled were up 3%, much of that from prescriptions coming out of the Walgreens-Express Scripts dispute (patients that Rite Aid plans on keeping), but that isn't the only reason Rite Aid's pharmacy business is on the rise.
Rite Aid's Rite Care Prescription Advisor, an opt-in program that illustrates for patients what their prescription-drug adherence looks like, now boasts 300,000 patients. While patients opt-in to review those adherence results for themselves, Rite Aid pharmacists also are utilizing those reports in their one-on-one consultations with patients. "We believe that one-on-one interaction with the pharmacist is an important way [to improve compliance]," noted John Standley, Rite Aid chairman, president and CEO, to Wall Street analysts Thursday morning. That improved compliance benefits Rite Aid through both an increase in prescriptions filled over the course of a year, as well as the increased in personalized interactions between Rite Aid pharmacist and Rite Aid patient.